相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differential effects of FXR or TGR5 activation in cholangiocarcinoma progression
O. Erice et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
FXR Acts as a Metastasis Suppressor in Intraheptic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition
Bei Lv et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis
Michael D. Thompson et al.
HEPATOLOGY (2018)
Bile acids and colon cancer: Is FXR the solution of the conundrum?
Raffaella Maria Gadaleta et al.
MOLECULAR ASPECTS OF MEDICINE (2017)
Cryopreservation protocol for human biliary tree stem/progenitors, hepatic and pancreatic precursors
Lorenzo Nevi et al.
SCIENTIFIC REPORTS (2017)
Hyaluronan coating improves liver engraftment of transplanted human biliary tree stem/progenitor cells
Lorenzo Nevi et al.
STEM CELL RESEARCH & THERAPY (2017)
TGF-β signaling is an effective target to impair survival and induce apoptosis of human cholangiocarcinoma cells: A study on human primary cell cultures
Anna Maria Lustri et al.
PLOS ONE (2017)
Comparative potency of obeticholic acid and natural bile acids on FXR in hepatic and intestinal invitro cell models
Yuanyuan Zhang et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2017)
Metabolic Profile of Obeticholic Acid and Endogenous Bile Acids in Rats with Decompensated Liver Cirrhosis
A. Roda et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2017)
Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage
J. E. Edwards et al.
CTS-Clinical and Translational Science (2016)
Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice
Yang Xu et al.
HEPATOLOGY (2016)
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesus M. Banales et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
FXR agonists enhance the sensitivity of biliary tract cancer cells to cisplatin via SHP dependent inhibition of Bcl-xL expression
Wei Wang et al.
ONCOTARGET (2016)
Cancer and liver cirrhosis: implications on prognosis and management
Matthias Pinter et al.
ESMO OPEN (2016)
Profiles of Cancer Stem Cell Subpopulations in Cholangiocarcinomas
Vincenzo Cardinale et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Prevention of Spontaneous Hepatocarcinogenesis in Farnesoid X Receptor-Null Mice by Intestinal-Specific Farnesoid X Receptor Reactivation
Chiara Degirolamo et al.
HEPATOLOGY (2015)
Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type
Shinichi Aishima et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures
Alice Fraveto et al.
PLOS ONE (2015)
Evidence for multipotent endodermal stem/progenitor cell populations in human gallbladder
Guido Carpino et al.
JOURNAL OF HEPATOLOGY (2014)
Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features
Jau-Yu Liau et al.
MODERN PATHOLOGY (2014)
Bile acid receptors as targets for drug development
Frank G. Schaap et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
Semisynthetic Bile Acid FXR and TGR5 Agonists: Physicochemical Properties, Pharmacokinetics, and Metabolism in the Rat
Aldo Roda et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Sumera Rizvi et al.
GASTROENTEROLOGY (2013)
Downregulation of nuclear receptor FXR is associated with multiple malignant clinicopathological characteristics in human hepatocellular carcinoma
Hongying Su et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
MicroRNA-421 functions as an oncogenic miRNA in biliary tract cancer through down-regulating farnesoid X receptor expression
Xiang-yu Zhong et al.
GENE (2012)
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Shahid A. Khan et al.
GUT (2012)
Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes
Mina Komuta et al.
HEPATOLOGY (2012)
Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis
Sigurd Lax et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
No Correlation between the Expression of FXR and Genes Involved in Multidrug Resistance Phenotype of Primary Liver Tumors
P. Martinez-Becerra et al.
MOLECULAR PHARMACEUTICS (2012)
FXR Controls the Tumor Suppressor NDRG2 and FXR Agonists Reduce Liver Tumor Growth and Metastasis in an Orthotopic Mouse Xenograft Model
Ulrich Deuschle et al.
PLOS ONE (2012)
Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity
Vincenzo Cardinale et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2012)
Carcinogenicity of deoxycholate, a secondary bile acid
Carol Bernstein et al.
ARCHIVES OF TOXICOLOGY (2011)
Proteomics for the discovery of nuclear bile acid receptor FXR targets
Cissi Gardmo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Impact of bile acids on the growth of human cholangiocarcinoma via FXR
Jiaqi Dai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
Clinical diagnosis and staging of cholangiocarcinoma
Boris Blechacz et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression
C. Giordano et al.
ONCOGENE (2011)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Farnesoid X Receptor Deficiency in Mice Leads to Increased Intestinal Epithelial Cell Proliferation and Tumor Development
Rengasamy R. M. Maran et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Role of Bile Acids and Bile Acid Receptors in Metabolic Regulation
Philippe Lefebvre et al.
PHYSIOLOGICAL REVIEWS (2009)
Farnesoid X Receptor Antagonizes Nuclear Factor κB in Hepatic Inflammatory Response
Yan-Dong Wang et al.
HEPATOLOGY (2008)
Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor
Fan Yang et al.
CANCER RESEARCH (2007)
FXR, a multipurpose nuclear receptor
Florence Y. Lee et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
The Farnesoid X receptor - A molecular link between bile acid and lipid and glucose metabolism
T Claudel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Emodin down-regulates androgen receptor and inhibits prostate cancer cell growth
TL Cha et al.
CANCER RESEARCH (2005)
6α-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity
R Pellicciari et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
分享论文
